mesamarketing, Author at Acomhal Research - Page 2 of 3

About mesamarketing

This author has not yet filled in any details.
So far mesamarketing has created 28 blog entries.

Fralin Biomedical Research Institute biotech spin-out raises additional $305,000 in investments (VT News)

mesamarketing2024-08-23T22:03:04+00:00

Comments Off

CIT GAP Funds Invests in Acomhal to Advance Therapies for Cancer Treatment (CIT)

mesamarketing2024-08-23T21:58:23+00:00

Comments Off

Virginia Tech researchers developing new potential treatment for breast cancer (WFXR)

mesamarketing2024-08-23T21:49:04+00:00

Comments Off

STTR Funding Catalyzes Acomhal’s Triple Negative Breast Cancer Treatment Research

mesamarketing2024-08-23T17:56:11+00:00

Your Content Goes Here Your Content Goes Here Acomhal ...

Comments Off

Fralin Biomedical Research Institute biotech spin-off seeks potential breast cancer treatment (VT News)

mesamarketing2024-08-23T22:03:44+00:00

Comments Off

Scientists identified novel cellular mechanism that can lead to cancer metastasis (Tech Explorist)

mesamarketing2024-08-23T22:01:35+00:00

Comments Off

VTCRI scientists identify novel cellular mechanism that can lead to cancer metastasis (EurekAlert)

mesamarketing2024-08-23T21:50:56+00:00

Comments Off

Acomhal Research Receives STTR Funding for Glioblastoma Cancer Stem Cell Research

mesamarketing2024-08-23T17:56:15+00:00

Your Content Goes Here Your Content Goes Here Acomhal ...

Comments Off

Acomhal Research Earns National APLU and AAU Recognition

mesamarketing2024-08-23T17:56:19+00:00

Your Content Goes Here Your Content Goes Here Acomhal ...

Comments Off

Virginia Tech biomedical spinoff cited for innovation by national university associations (VT News)

mesamarketing2024-08-23T22:04:28+00:00

Comments Off